SK284903B6 - Spôsob výroby 1-(6-metylpyridín-3-yl)-2-[(4- (metylsulfonyl)fenyl]etanónu a medziprodukty - Google Patents

Spôsob výroby 1-(6-metylpyridín-3-yl)-2-[(4- (metylsulfonyl)fenyl]etanónu a medziprodukty Download PDF

Info

Publication number
SK284903B6
SK284903B6 SK972-2001A SK9722001A SK284903B6 SK 284903 B6 SK284903 B6 SK 284903B6 SK 9722001 A SK9722001 A SK 9722001A SK 284903 B6 SK284903 B6 SK 284903B6
Authority
SK
Slovakia
Prior art keywords
methyl
methylpyridin
formula
carbaldehyde
acetonitrile
Prior art date
Application number
SK972-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK9722001A3 (en
Inventor
Erich Armbruster
Yves Bessard
David Kuo
James Edward Leresche
Ralf Proplesch
Jean-Paul Roduit
Original Assignee
Lonza Ag
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag, Merck & Co., Inc. filed Critical Lonza Ag
Publication of SK9722001A3 publication Critical patent/SK9722001A3/sk
Publication of SK284903B6 publication Critical patent/SK284903B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SK972-2001A 1999-01-14 2000-01-13 Spôsob výroby 1-(6-metylpyridín-3-yl)-2-[(4- (metylsulfonyl)fenyl]etanónu a medziprodukty SK284903B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99100590 1999-01-14
US14599699P 1999-07-29 1999-07-29
PCT/EP2000/000240 WO2000042014A2 (de) 1999-01-14 2000-01-13 1-(6-methylpyridin-3-yl)-2-((4-(methylsulfonyl)phenyl)ethanon und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
SK9722001A3 SK9722001A3 (en) 2001-12-03
SK284903B6 true SK284903B6 (sk) 2006-02-02

Family

ID=34089809

Family Applications (1)

Application Number Title Priority Date Filing Date
SK972-2001A SK284903B6 (sk) 1999-01-14 2000-01-13 Spôsob výroby 1-(6-metylpyridín-3-yl)-2-[(4- (metylsulfonyl)fenyl]etanónu a medziprodukty

Country Status (15)

Country Link
EP (2) EP1394149B1 (hu)
JP (1) JP4765167B2 (hu)
CN (2) CN1170820C (hu)
AT (2) ATE253559T1 (hu)
AU (1) AU2290800A (hu)
CA (2) CA2359958C (hu)
CZ (1) CZ302270B6 (hu)
DE (2) DE50004327D1 (hu)
DK (2) DK1159270T3 (hu)
ES (2) ES2209807T3 (hu)
HU (1) HUP0105124A3 (hu)
IL (1) IL143981A0 (hu)
PT (2) PT1394149E (hu)
SK (1) SK284903B6 (hu)
WO (1) WO2000042014A2 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104725300A (zh) * 2015-02-28 2015-06-24 宁波九胜创新医药科技有限公司 一种1-(6-甲基吡啶-3-基)-2-(4-甲磺酰基苯基)乙酮的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313683A (en) * 1963-04-22 1967-04-11 Lilly Co Eli Nematocidal and fungicidal methods
FR2074674A1 (en) * 1970-01-16 1971-10-08 Simafex Sulphonamide/aldehyde-bisulphite complexes - antibacterials with very high solubility in water
US4155909A (en) * 1977-06-13 1979-05-22 Philip Morris Incorporated 2-Alkyl nicotinoids and processes for their production
US5596008A (en) * 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
HU227732B1 (en) * 1996-07-18 2012-01-30 Merck Frosst Canada Ltd Substituted pyridine derivatives as selective cyclooxigenase-2 inhibitors and use thereof
TW492959B (en) * 1997-04-18 2002-07-01 Merck & Co Inc Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
AR015938A1 (es) * 1997-09-25 2001-05-30 Merck Sharp & Dohme Procedimiento para preparar diaril piridinas utiles como inhibidores cox-2 y compuesto intermediario
AU759469B2 (en) * 1998-04-24 2003-04-17 Merck Sharp & Dohme Corp. Process for synthesizing cox-2 inhibitors

Also Published As

Publication number Publication date
HUP0105124A3 (en) 2002-05-28
CN1359374A (zh) 2002-07-17
HUP0105124A2 (hu) 2002-04-29
CN1583723A (zh) 2005-02-23
DE50009312D1 (de) 2005-02-24
CN1170820C (zh) 2004-10-13
DK1394149T3 (da) 2005-04-04
DE50004327D1 (de) 2003-12-11
PT1394149E (pt) 2005-05-31
DK1159270T3 (da) 2004-02-23
CZ302270B6 (cs) 2011-01-19
CN1281589C (zh) 2006-10-25
CA2359958C (en) 2006-04-04
AU2290800A (en) 2000-08-01
ES2209807T3 (es) 2004-07-01
CA2485739C (en) 2009-09-22
SK9722001A3 (en) 2001-12-03
CZ20012457A3 (cs) 2002-01-16
JP4765167B2 (ja) 2011-09-07
WO2000042014A2 (de) 2000-07-20
EP1394149B1 (de) 2005-01-19
CA2485739A1 (en) 2000-07-20
EP1394149A1 (de) 2004-03-03
ATE287396T1 (de) 2005-02-15
EP1159270A2 (de) 2001-12-05
IL143981A0 (en) 2002-04-21
EP1159270B1 (de) 2003-11-05
ATE253559T1 (de) 2003-11-15
JP2003518002A (ja) 2003-06-03
PT1159270E (pt) 2004-03-31
WO2000042014A3 (de) 2000-12-07
CA2359958A1 (en) 2000-07-20
ES2235138T3 (es) 2005-07-01

Similar Documents

Publication Publication Date Title
SK284903B6 (sk) Spôsob výroby 1-(6-metylpyridín-3-yl)-2-[(4- (metylsulfonyl)fenyl]etanónu a medziprodukty
US20010012900A1 (en) 3-(1-hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-one a process for the preparation thereof and the use thereof
US7141673B1 (en) 1-(6-methylpyridine-3-yl)-2-[4-(methylsulphonyl) phenyl] ethanone and method for its preparation
Ramana Reddy et al. Thioglycolates in the Synthesis of Bis (styryl)-sulfones
EP0279643B1 (en) Cyanoguanidine derivatives, the preparation thereof and their use for the synthesis of cimetidine
JP3031279B2 (ja) 2−アルコキシ−6−(トリフルオロメチル)ピリミジン−4−オルの製造方法
Boddaert et al. Towards New Sila-or Germa-Derivatives of Motesanib
CN110903238B (zh) 一种伐度司他的制备方法
TWI282789B (en) Process for the preparation of 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl)phenyl]ethanone
HU213533B (en) Process for producing 3-(hydroxymethyl)-1-propargylimidazolidine-2,4-dione
JPH0680048B2 (ja) オトロ酸の製法
Nadir et al. Reaction of N-arylsulfonylaziridines with dimethylsulfoxonium methylide in the presence of 18-crown-6–An improved synthesis of 2-aryl-N-arylsulfonylazetidines
US4487721A (en) Process for producing 2-amino-2-arylacetonitriles
JP4018816B2 (ja) シクロヘプテノン誘導体及びその製造方法並びにそれを利用してシクロヘプトイミダゾール誘導体を製造する方法
JP4061901B2 (ja) 3−カルボキシインダゾール誘導体及びその製法
JP4058960B2 (ja) インダゾール誘導体及びその製法
JPH0316339B2 (hu)
JPH03127780A (ja) アニリノピリミジン誘導体
JPH0152384B2 (hu)
JPS58413B2 (ja) (n−メチルピリル−2)アセトチオアミド誘導体
CS273077B1 (en) Method of 2-phenyl-4-chloro-5-methoxy-3 (2h)-pyridazinone preparation
FR2741068A1 (fr) Procede de preparation de 7,8-dihydroisoquinolein-5(6h)-one

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20120113